Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)

The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and the increasing adoption of premium-priced devices such as CRT devices, single-chamber leadless pacemakers, and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…
Report
Neurostimulation Devices – Market Insights – United States
The US neurostimulation device market will be driven by strategic acquisitions, rapid adoption of novel technologies and increasing availability of advanced products, and new approvals and device…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…